expression of bvg-regulated genes and an avirulent phenotype (15, 16). In this paper we report the complete nucleotide sequence

Similar documents
Synergistic Binding of RNA Polymerase and BvgA Phosphate to the Pertussis Toxin Promoter of Bordetella pertussis

BvgAS Is Sufficient for Activation of the Bordetella pertussis ptx Locus in Escherichia coli

Identification of a Locus Required for the Regulation of bvg- Repressed Genes in Bordetella pertussis

1. Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and

bvg Repression of Alcaligin Synthesis in Bordetella bronchiseptica Is Associated with Phylogenetic Lineage

Neither the Bvg Phase nor the vrg6 Locus of Bordetella pertussis Is Required for Respiratory Infection in Mice

Activation of the vrg6 Promoter of Bordetella pertussis by RisA

(Received 24 February 1988)

Regulatory Mutants of Bordetella bronchiseptica in a

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Mechanisms and Pathways of AMR in the environment

Developmental expression of synthetic cis-regulatory systems composed of spatial control elements from two different genes

Mechanism of antibiotic resistance

Filamentous Hemagglutinin of Bordetella bronchiseptica Is Required for Efficient Establishment of Tracheal Colonization

Antimicrobial Resistance

Regulated. bronchiseptica and B. pertussis. Deletion of bvgas or modulation. In this phase vag genes are not induced and vrg loci

on December 14, 2018 by guest

How the eye sees. Properties of light. The light-gathering parts of the eye. 1. Properties of light. 2. The anatomy of the eye. 3.

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

Antimicrobials & Resistance

Probing the Function of Bordetella bronchiseptica Adenylate Cyclase Toxin by Manipulating Host Immunity

Antibiotics & Resistance

Phenotypic modulation of the Bvg+ phase is not required for pathogenesis and. transmission of Bordetella bronchiseptica in swine

Evolution of the Bordetella autotransporter Pertactin: identifications of regions subject to positive selection

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Antibiotic Resistance in Bacteria

Epigenetic regulation of Plasmodium falciparum clonally. variant gene expression during development in An. gambiae

Overview. There are commonly found arrangements of bacteria based on their division. Spheres, Rods, Spirals

Investigation of the molecular biology and contribution to virulence of Bordetella bronchiseptica urease

Antimicrobial use in poultry: Emerging public health problem

The Bvg Virulence Control System Regulates Biofilm Formation in Bordetella bronchiseptica

THE COST OF COMPANIONSHIP

Methicillin-Resistant Staphylococcus aureus

Evaluation of the Role of the Bvg Intermediate Phase in Bordetella pertussis during Experimental Respiratory Infection

Virulence of Bordetella bronchiseptica: Role of Adenylate Cyclase-Hemolysin

Antimicrobial Therapy

Molecular Characterization of Two Bordetella bronchiseptica Strains Isolated from Children with Coughs

WHY IS THIS IMPORTANT?

Electron Microscopic Observations on Ciliated Epithelium of Tracheal Organ Cultures Infected with Bordetella bronchiseptica

An#bio#cs and challenges in the wake of superbugs

Evolution of antibiotic resistance. October 10, 2005

Lecture 6: Fungi, antibiotics and bacterial infections. Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance

Antimicrobial agents

Role of the Type III Secretion System in a Hypervirulent Lineage of Bordetella bronchiseptica

Genes What are they good for? STUDENT HANDOUT. Module 4

A Homologue of an Operon Required for DNA Transfer in Agrobacterium Is Required in Brucella abortus for Virulence and Intracellular Multiplication

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

A key regulatory mechanism of antimicrobial resistance in pathogenic Acinetobacter baumannii

BioSci 110, Fall 08 Exam 2

Genotypes of Cornel Dorset and Dorset Crosses Compared with Romneys for Melatonin Receptor 1a

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Received 22 April 2011/Accepted 30 June 2011

Antibiotic resistance a mechanistic overview Neil Woodford

A. Pulse-field gel of hummingbird genomic DNA. B. Bioanalyzer plot of hummingbird SMRTbell library

MATTHEW S. CONOVER. A Dissertation Submitted to the Graduate Faculty of WAKE FOREST UNIVERSITY GRADUATE SCHOOL OF ARTS AND SCIENCES

Expression of Pertussis Toxin in bvg-negative Bordetella bronchiseptica

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

SUPPLEMENTAL MATERIALS AND METHODS

husband P, R, or?: _? P P R P_ (a). What is the genotype of the female in generation 2. Show the arrangement of alleles on the X- chromosomes below.

Bordetella bronchiseptica: A Candidate Mucosal Vaccine Vector

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Growth Phase- and Nutrient Limitation-Associated Transcript Abundance Regulation in Bordetella pertussis

Prof Michael O Neill Introduction to Evolutionary Computation

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate

MRSA ST398 from swine and cattle

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

INFECTION AND IMMUNITY, June 1999, p Vol. 67, No. 6. Copyright 1999, American Society for Microbiology. All Rights Reserved.

In Vitro and In Vivo Characterization of a Bordetella bronchiseptica Mutant Strain with a Deep Rough Lipopolysaccharide Structure

Jerry and I am a NGS addict

Randall Singer, DVM, MPVM, PhD

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

Microbiology ( Bacteriology) sheet # 7

Phenotype Observed Expected (O-E) 2 (O-E) 2 /E dotted yellow solid yellow dotted blue solid blue

Bi156 Lecture 1/13/12. Dog Genetics

Conformational changes of inter-domain linker mediate mechanical. signal transmission in sensor-kinase BvgS

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

PFGE and pertactin gene sequencing suggest limited genetic variability within the Finnish Bordetella parapertussis population

Next Wednesday declaration of invasive species due I will have Rubric posted tonight Paper is due in turnitin beginning of class 5/14/1

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys

Supplemental Information. A Deletion in the Canine POMC Gene. Is Associated with Weight and Appetite. in Obesity-Prone Labrador Retriever Dogs

Martin Chénier, Ph.D. Microbiology. Antibiotics in Animal Production: Resistance and Alternative Solutions

SUPPLEMENTARY MATERIAL

chapter 15 microbial mechanisms of pathogenicity

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Approved by the Food Safety Commission on September 30, 2004

Evolution in dogs. Megan Elmore CS374 11/16/2010. (thanks to Dan Newburger for many slides' content)

What is antimicrobial resistance?

Epitope Mapping of the Brucella melitensis BP26 Immunogenic Protein: Usefulness for Diagnosis of Sheep Brucellosis

Genetics for breeders. The genetics of polygenes: selection and inbreeding

Pipestone Veterinary Services

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy in Boxer dogs: a cautionary tale for molecular geneticists.

ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED

Worksheet for Morgan/Carter Laboratory #9 Mendelian Genetics II: Drosophila

Transcription:

Proc. Natl. Acad. Sci. USA Vol. 86, pp. 6671-6675, September 1989 Genetics Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins (vir/bvga, bvgb, and bvgc/two-component regulatory systems/virulence regulation) BEATRICE ARic6*, JEFF F. MILLERt, CRAIG Royt, ScoTT STIBITZt, DENISE MONACKt, STANLEY FALKOWt, RoY GRoss*, AND RINo RAPPUOLI* *Sclavo Research Center, Via Fiorentina 1, 53100 Siena, Italy; tdepartment of Microbiology and Immunology, Stanford University, Stanford, CA 94305; and tcenter for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 Contributed by Stanley Falkow, May 9, 1989 ABSTRACT The bvg locus of Bordetella pertussis is required for coordinate regulation of several factors associated with virulence. The control system is modulated by various environmental signals, including low temperature, MgSO4, and nicotinic acid. The nucleotide sequence of the bvg region has been determined and three open reading frames, bvga, bvgb, and bvgc, are present. Twelve-base-pair linker insertion mutations in any of these open reading frames result in a Bvgphenotype. The predicted protein products of bvga and bvgc share homology with a family of prokaryotic regulatory proteins that respond to environmental stimuli and are members of two-component sensory transduction systems. We propose a model in which BvgB and the N-terminal portion of BvgC are localized in the periplasm. Environmental signals are recognized, transduced to the cytoplasmic portion of BvgC, and then transmitted to BvgA, a positive regulator of transcription. The host-microbe interaction that occurs during infection and disease is a dynamic process in which the infecting organism encounters a variety of external conditions. A need for efficient adaptation to changing environments has resulted in the evolution of specialized systems that control the expression of bacterial virulence (1). Bordetella pertussis is a human pathogen that causes whooping cough. This organism produces a number of factors that appear to be involved in pathogenesis (2). Filamentous hemagglutinin (3) and pili (4) probably play a role in adherence of the bacteria to ciliated epithelial cells in the upper respiratory tract. Other products, such as tracheal cytotoxin (5), dermonecrotic toxin (6), hemolysin (6, 7), adenylate cyclase toxin (8), and pertussis toxin (7, 9), may be involved in local damage, evasion of host defenses, and systemic disease. With the exception of tracheal cytotoxin, expression of these virulence factors is coordinately regulated and requires the products of the bvg (flordetella yvirulence gene) locus, which was initially designated vir (10-12). Positive control of the pertussis toxin operon by bvg has been shown to occur at the level of transcription (13). Inactivation of the bvg locus by transposon mutagenesis results in a loss of virulence (7). Alternative virulence states of B. pertussis also occur by two mechanisms, phase variation and phenotypic modulation. Phase variation (11) is due to a low-frequency reversible alteration in the bvg locus that, for the Tohama III strain, has recently been shown to involve a frameshift mutation in bvg (14). In contrast, phenotypic modulation is a reversible response to environmental conditions. Growth at low temperature (280C vs. 370C), or in the presence of MgSO4 or nicotinic acid, results in a lack of The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 1734 solely to indicate this fact. expression of bvg-regulated genes and an avirulent phenotype (15, 16). In this paper we report the complete nucleotide sequence of the B. pertussis bvg region. The predicted products of two bvg loci are homologous to a family of regulatory proteins that transmit sensory signals using a conserved twocomponent motif (1, 17). A model for the role of the bvg products in sensory transduction and gene regulation is also presented. MATERIALS AND METHODS Bacterial Strains. B. pertussis strains BP165 (Bvg'; ref. 9), BP536 (Bvg'; ref. 10), and the TnS insertion derivatives BP347 (virl::tns; ref. 10) and BP359 (vir2::tns; ref. 11) have been described. BP370 is a virulent phase derivative ofbp326 (11). Escherichia coli strain SmlO (18) was used for IncPmediated conjugative transfer from E. coli to B. pertussis as described below. Chloramphenicol Acetyltransferase (CAT) Fusions. A promoterless CAT gene (19) was isolated as a BamHI fragment and inserted into the Bgl II site of bvgc in both orientations. CAT fusions were returned to the chromosome of BP370 by homologous recombination (20). The orientation of the fusions within the B. pertussis chromosome was confirmed by Southern analysis. The resulting CAT fusion strains CF1470 and CF1770 carry the CAT gene in the orientations shown in Fig. 1. CAT assays were performed as described (9). Nucleotide Sequence Determination. The nucleotide sequence of the 5995-base-pair (bp) EcoRI-Xho I fragment shown in Fig. 1 was determined by the standard dideoxy chain-termination method (21). The sequence of both strands was obtained by using synthetic oligonucleotide primers. Linker Insertion Mutagenesis. Twelve-base-pair linker insertions were introduced into the bvg region at the locations shown in Fig. 1. Insertions at Sal I, Pst I, or Mlu I sites consisted of the sequence 5'-GACCTGCAGGTC-3', 5'- GCTCGAGCTGCA-3', or 5'-CGCGTCTCGAGA-3', respectively. Mutations were constructed in E. coli and transferred to B. pertussis by shuttle mutagenesis (20). The structures of the bvg loci in the resulting strains were verified by Southern blot analysis. Sequence Analysis. The Sequence Analysis Software Package distributed by the University of Wisconsin Genetics Computer Group (22), running on a VAX/VMS computer, PC Gene (Intelligenetics), and Genepro (Riverside Scientific, Seattle) were used for protein and nucleic acid sequence analysis, database searching, and homology assessment. Abbreviations: CAT, chloramphenicol acetyltransferase; ORF, open reading frame. ITo whom reprint requests should be addressed. 6671

6672 Genetics: Arico' et al. RESULTS B. pertussis bvg Locus. The bvg locus was initially identified by transposon TnS insertions in the chromosomes of B. pertussis strains BP347 and BP359 (10, 11). The bvg locus has been cloned (12) and a restriction map is shown in Fig. 1. To investigate the transcriptional activity of bvg, a promoterless CAT gene was inserted in both orientations at the unique Bgl II site within the bvg sequences of strain BP370. The orientations and insertion point of the bvg-cat fusions carried by CF1470 and CF1770 were confirmed by Southern blot analysis and are shown in Fig. 1. The Bgi II site in bvg lies between the sites of TnS insertion in BP347 and BP359. Insertion of the CAT cassette at this site disrupts the bvg locus, CF1470 and CF1770 have a Bvg- phenotype. CAT activity was detected only in CF1770, in which the CAT gene is present in the left to right orientation as depicted in Fig. 1 (data not shown). Introduction of a plasmid carrying the wild-type bvg locus into these strains results in a Bvg+ phenotype and does not alter the relative pattern of CAT expression. We conclude from these results that the bvg locus is transcribed in Bvg+ and Bvg- strains and that the direction of transcription is from left to right as shown in Fig. 1. Nucleotide Sequence of the bvg Locus. The boundaries of the bvg locus are contained within a 6-kb DNA fragment delimited by the EcoRI-Xho I restriction sites shown in Fig. 1. In B. pertussis (10, 11) and E. coli (12), Bvg- TnS insertions map within this region. In addition, this fragment is sufficient for transcriptional activation of anfljab-laczya operon fusion in E. coli in a manner that responds to environmental signals that modulate virulence expression by B. pertussis (J.F.M., C.R., and S.F., unpublished data). We have determined the complete nucleotide sequence of the 5995-bp EcoRI-Xho I fragment containing the bvg locus and have deposited this sequence in the EMBL/GenBank data base (accession no. M25401). The overall G+C content of the sequence is 65%, a value similar to that of other B. pertussis sequences (4, 8, 23). As summarized in Fig. 1, three tandem ORFs with codon usage patterns typical of B. pertussis genes are detected. These ORFs, which may form an operon, are designated bvga (Bordetella virulence gene A), bvgb, and bvgc. Putative ribosomal binding sites fofeach of these loci are located 7-14 nucleotides upstream from AUG sequences. The proposed direction of bvg expression corresponds to the direction of transcription detected with the CAT fusions described above. bvga, bvgb, and bvgc are predicted to encode proteins of 209, 275, and 936 amino acids, with molecular weights of Proc. Natl. Acad. Sci. USA 86 (1989) 23,000, 30,000, and 102,000, respectively. Characteristic features of a prokaryotic signal peptide are found at the N terminus of BvgB. Two basic amino acids at positions 6 and 10 are followed by 23 uncharged, predominantly hydrophobic residues. This pattern is similar to that present at the N termini of the E. coli Tsr, Tar, and Tap chemoreceptors (24). BvgC contains two hydrophobic segments. The first, which may also have a role in export, contains a lysine residue at position 8 followed by a relatively short 13-amino acid hydrophobic core. In addition, a sequence of 22 hydrophobic residues beginning at position 240 is predicted to form a transmembrane helix [transfer free energy - +44 kcal/mol (1 kcal = 4.18 kj); ref. 25] and is followed by a highly basic stretch of 9 amino acids. This putative transmembrane region is similar to those found in several bacterial proteins that span the inner membrane, such as the Agrobacterium protein (26) and the M13 procoat protein (27). Although sequences upstream of bvga are unusually rich in A+T content, putative bacterial promoters (28) could not be found. In addition, structures resembling constitutive terminators (Rho independent; ref. 29) do. not appear to be present. Sequences downstream of bvgc show a low coding probability in the left to right orientation. The probability of coding in this region is high in the opposite strand; however, no obvious ORFs have been identified. We have determined the sites of transposon TnS insertion in the Bvg- B. pertussis mutants BP347 and BP359 in relation to the bvg ORFs and found that these insertions map in bvgc and bvga, respectively (Fig. 1). BvgA and BvgC Belong to a Family of Regulatory Proteins Involved in Signal Transduction. The predicted amino acid sequences of BvgA, BvgB, and BvgC were compared to sequence entries in the National Biomedical Research Foundation database, and to sequences translated from the Gen- Bank database. Localized regions of homology were found between BvgA, BvgC, and members of a family of bacterial proteins that mediate signal transduction using a conserved "two-component" motif (Fig. 1; refs. 17 and 30). In these systems a "sensor" protein directly or indirectly perceives sensory stimuli and transmits a signal to a "regulator" protein that functions to control transcription or some other cellular function. Sensor proteins share a homologous C- terminal domain of =250 amino acids that has been termed the "transmitter," and regulator proteins typically share an N-terminal region of about 115 residues, which comprises the "receiver" (30). The central portion of BvgC (residues 423-655) shares homology with the transmitter domains of EnvZ (31), thab 4=...m BP359 (n) E M M P _LII +- bvga RECEIVER CF1470 CF1770 SCATSCPl S PS S. P Bll E I I l I linl L +' +T ^ bvgb bvgc s BP347 (Tn5) TRANSMITTER RECEIVER kb S S P E E X I I I I- + FIG. 1. Restriction map and features of the bvg locus. The 5995-bp EcoRI-Xho I fragment that contains the BP165 bvg locus is shown. The restriction map is derived from the nucleotide sequence. Arrows denote the position of transposon Tn5 insertions in strains BP359 and BP347. The location and orientation of the CAT fusions in CF1470 and CF1770 are also indicated. bvga, bvgb, and bvgc are open reading frames (ORFs) predicted from the sequence. Transmitter and receiver indicate the relative locations of homologous sequences in the predicted protein products. Solid portions of the arrows indicate putative N-terminal signal sequences in BvgB and BvgC and the predicted transmembrane domain of BvgC. The location and orientation of the gene encoding filamentous hemagglutinin (ffiab) are also shown. Positions of 12-bp linker insertion mutations at Mlu I, Sal I, and Pst I sites in the bvg region are indicated by upward vertical arrows. +, Insertions resulting in a Bvg+ phenotype; -, insertions giving a Bvg- phenotype. E, EcoRI; M, Mlu I; P, Pst I; S, Sal I; BII, Bgl II; X, Xho I. kb, Kilobase. i

Genetics: Arico et al. (32), (26), (33), (34), (35), and other transmitter proteins (Fig. 2). The similarity to, a factor required for positive control of nitrogen fixation by Rhizobium (32), is observed over the entire length of. In addition, regions of similarity with, a sensor protein involved in Agrobacterium virulence control (26), can be found extending from the transmitter to the N terminus of BvgC. and contain predicted transmembrane domains similar to the one identified in BvgC, and has been shown to be located in the Agrobacterium cytoplasmic membrane (26). BvgA and BvgC also contain receiver domains (Fig. 3). These are located at the N terminus of BvgA (residues 1-115) and, surprisingly, at the C terminus of BvgC (residues 672-789). The homology between BvgA, FixJ (32), and UhpA (40) extends over the entire length of these proteins, whereas most other similarities are confined to N-terminal sequences. FixJ is a transcriptional activator that acts in conjunction with (see above), and UhpA positively regulates expression of the sugar-phosphate transporter gene uhpt in E. coli (40). Many proteins that contain receiver modules are transcriptional activators that fall into different categories according to their C-terminal sequences (17). BvgA appears to belong to a group that previously has been shown to contain FixJ and UhpA (32). A measure of the significance of this relationship was obtained by using the RDF program of Lipman and Pearson (41). When BvgA was compared with randomly permuted versions of the FixJ or UhpA sequences, the optimized alignments scored 14.7 (FixJ) and 16.5 (UhpA) standard deviations above the mean for 20 randomized com- Proc. Natl. Acad. Sci. USA 86 (1989) 6673 parisons. Although FixJ and UhpA have been suggested to contain helix-turn-helix DNA binding motifs (32, 40), we find no such evidence of this motif in BvgA, FixJ, or UhpA using the refined method for identification of helix-turn-helix sequences recently described by Brennan and Matthews (42). BvgA, BvgB, and BvgC Are Required for the Expression of Virulence Factors. Previous identification of the bvg locus in B. pertussis has relied on transposon TnS insertions that are capable of causing polar effects on distal transcription (10, 11). To determine if each of the three bvg ORFs is required for expression of virulence factors, 12-bp linker insertion mutations were introduced into the Sal I, Pst I, and Mlu I sites shown in Fig. 1. Since these mutations result in an in-frame insertion of 4 amino acids, polar effects would not be generated. Insertions at the Mlu I site in bvga, the Sal I site in bvgb, and several Pst I and Sal I sites in bvgc cause a Bvg- phenotype as shown by the loss of hemolytic activity. Mutations at the Mlu I site preceding bvga, or the Sal I and Pst I sites located downstream from bvgc, had no effect on hemolytic activity. These results indicate that bvga, bvgb, and bvgc are required for expression of virulence factors by B. pertussis. DISCUSSION The bvg regulon of B. pertussis includes several unlinked genes and operons that encode virulence factors. Expression of these loci, and their response to environmental signals, require the products of the bvg locus in trans (1, 10, 12, 43). An additional set of genes that are repressed by bvg and BvgC 5 PVVKVAVLNLFAPFTLFRTDEQFGGISAAVLQLLQLRTGLDE'EIIGVD.TVEELIAKLRSGEADMAGALFVNSAR.ESF..LSFSRPYVRNGMVIVTRQDPDAPVDADHLDGR....TV 115 :A: :: A :A At A*A: :: :: ::: :A:A:: A* **Ai ** : : :: :A*A : : :: 32 AVLAIGPIKNEKSIEAILTELQSIDVDCALLQRNVLRA..HAGLLRNYRPLMVPLGRVRSSIANLQQ. LFKK.ARVEDVGELSELLARLKSSINT... TDAAVASFGAQNVVFESL 141 MIRAEPIGEGLLLFSFIPAILWALIGGRNP. ILFAAGLSLVAAVSH : A : : : : A A *A: A A : : * ALVRNSAAIPLLQRRYPQ... AKVVTADNPSEAMLMVANGQADAWQTQISASYYVNRYFAGKLRIASALDLPPAEIALATIRGQTELMSILNKALYSISNDE. LAS. IISRHRGSDG A 2A AA * : AAA :: : AA : :3::: As:A : : :A : : : A: * : ::: A : A ATFNQS. ISSLLRTSDSRDLNAAKV.. PELGYL. MLQFS.FRPNTELALQITQSLDQLQMSTNADKVAIQEVVRNGRVILGVLPRLNErVKLVQ. ASGTFEDITKKLQRAYLEADSLARV 46 228 254 EDvZ BvgC EnvZ QQIS. SAWGPSWELLVFG.SAVLLIVALGEVLEAARRAIDRTE1VVRARDAHLRSIML'VPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLR... ILMPEPYRHDGYLQR : : : *: A A AA:: A A A:*A t :A:: *A:: A :A:: A A: AA : :A: A A A : A A DPRTWYAYRNEIYLLIGLGLLSALLFLSWIVYLRRQ IRQRRARLND LEFMVIWTPNPIYVRDKEKMECRDYMLGVTDAVLGKTIPEANVVG PAREELLT A :* A : AA A,* : :: *A: : s : A: :: 3...VEQRVRTFLGAVSVF'FCFGIVILVHKLRRRTl)RLARRLDF-EEVIKK IGVCFMlSTErKQSLKSSAEAALGTIENFFEANQCVLGLVNVTElIAETFSASAPPPSHNERIRKI YMATGEKRIIGIDRWSGQRKDGS..TFPMKLAVGEMRGE 'GFIRDLTEREESAARLEQIQAELARLARL...... NEDGEMASTLAHELNQPLSA * A A A : : A A :*:::: : A AA A3: A: : : A :A: :**: A: A VA.M1E I.HIPYGDSLGELKGIIGGWIDITERAELLREADAAN... ATMSHEIRTPHIA A ::A :A:* A A : s :*A A : VSLVQADBIS IF-RDYPARKASCFNEAPRALVAF'KVSDRLVAVFCL-RDPVQPASSEVQIKCAAGCVVHYVIRCQTQRDILERRLKHAERLEAVGTLAGGIAHEFNILGV :*: :A: A*... MAGVSHDLRTPLTR : A: :*::: AA:... VRGLAHEIKNPLGG : :**AA:: A... FANVSHELRTPLTV : :**A: s**s... VYALTHELKSPLAA IANYSHGCTRLLRDMDD. AVATRIREALEEVASQSLRAGQIIKHLRFTKGEIE APMIRKLVEESAALALVGSREQGVRTFEY. LPGAEDVLVD... RIQVQQVLINLMR A AA* A2: *A A2 A A A : :* AA : t k A: At : IA AA :: AA** AA IIGKfLEA..LL MPRSQADASLLGILIK~GFLPRARLEARV'GAQGEVKDVVD D...PLRI4CQVLSNLVG At A A At : : A AAS* : : AA : * :: AA *: A* AA ILGYA. MAQNILHRR.TYARHYIDRINAESNRARLIIDQILALSRRRERTARPFNLSALVREIAPSLRVALPSEVEVDFNIQ...... SAQMIVEGNPLEIEQILMNLCX A :*A:: A : **: : AA* S A : A:: A :: :AA: s : A AAA : *A: I... RLATEMMSEQDGY... LAESINKDIEECNAIIEQFIDYLRTGQE.. MPMEADLNAVLGEVIAAESGYEREIETALY... PGSIEVKMHPLSIKRAVANV A: A IS: t* A A AAA : : A A t:sa : ::: ::*A A2 A A * A : A: L... RGAAQLLSKALP. DPSLLEYT. KVIIEQADRLRNLVDRLLGPQL.. PGTRVTESIHVAE... RVVTLVSMELPDNVRLI... RDYDPSLPELAHDPDQIEQVLLNIVR A A: : :A :AA*: A: AA AA*t : A : AAA : A:3: :: : : *: L... QGYLDffIEQPL. Ei.VREALHIRETQRMEGLVKQLLTLS.. XIEAPTLILLNEKVWPM. RVVEREAQTLSQKKQTF... TF. EIDNGLKVSGNEDQLRSAISNLVY A* : AA A A I : A AA: :AA * * AA : At* S *S I t *AAA t A: :**AA A*A: 3: :A A: S**: I... RGAAEILREGPPPE. WA. RE'TDILTQNARMQALVETLLRQA.. RLENRQEVVLTA. VDVAALFRRVSEARTVQLADEKITLHV..TPTEV.NVAAEPALLEQ... ALGNLLD 159 347 368 252 435 487 251 147 221 273 361 544 588 346 247 327 377 EnvZ NAIEAM.... RHVDRRELTIRTHPADPGEVAVVVEIXG= IPEEVAGQLFKPFV... TTK.ASGMGIGLSISKRIVEAHGGEKtVSKNEAGGATFRFT.. LPAYLDERIVAND# AAA A:: A A AAA AA:A AAAAAA ^ A3A A2AAAAA3A:*:*3 AA : : : :*A A: :: : A NAIKFT... TEGQVLAVTARPDGDAAHQFSVSDrCISEADQRQLFKPFSQVGGSAEAGP.APGTGLGL8I!RRLVELTLVMRSAPGVGTVSVDLRLTM.VEKSVQAAP. AA : 2 : : A AA* A A : : :AA : :AAAAAAA A A:A :AAAA : A A A: A: : NAAESV...YRSFVHKHVLANGTIPAGDYILLSTEDNGGGIGQAALPHIIFEPFTR... AQCGGTGLGLSTVHGHVSAMAGFVDVISTVGRGTRFMIYLP.TSAX.KPVNS... AAA A:A :2:: :A:AAAAA: A*:AA A :AAAAAA: A A A ::: :: A :AA: :: : NAARY.G.. NG.NI.K... VSSGTEPNRANFQVEDDGPGIAPEQRKHLFQPFVRGD. SA... RTISGTGLGLAIVQRIVDNHNGMLELGTSERGGLSIRANLPVPVTRAQGTTKEG# AA A A : : A :*AAA*AA*** AA A A A A :AAAAAA: : :A*: A :A :: A :AA: NALQALGPEGGLRTRTAFQLTLHGERYRLAARIDVWNGPGIPPHLQDTLFYPMVSG. Ṙ.EGLGLSIANLIDQHSGKIEFTSWP.GHTEFSVYLPIRK* AA: A I A:: :*A AAAAAAAAlA AA*AAAA3A t : 32::: A A AA :A A NAVN.. HPEGTHITVRWQRVPHGAESVENGPGIAPEHIPRLTERFYRVDKARSRQT..GGSGLGLAIVKHAVNHHESRLNIESTVGKGTRFSFVIPERLIAKNSD# AA:: AAA : : AA*A A A:AA: ::A: * * AAAA * : A:* **** AAAA A 2 3 A A : A : NAID.. FTPESGCITLSAEVDQEIVTLKVLDGSGIPDYALSRIFERFYSLPRANG.Q... KSSGLGLAPVSEVARLFNGEVTLRNVQE3GVLASLRL. HlffT# FIG. 2. Amino acid sequence comparisons between BvgC and members of bacterial sensory transduction systems that contain transmitter domains. Identical amino acids (*) and similar amino acids (:) between the adjacent sequences are indicated. The groups of similar amino acids are C; S, T, P, A, G; N, D, Q, E; M, I, L, V; F, Y, W. Proposed transmembrane domains and signal sequences are indicated by dashed lines. References for sequences are given in the Results. 464 655 704 450 349 431 474

6674 Genetics: Arico et al. Proc. Natl. Acad. Sci. USA 86 (1989) BvgA MYNKLIIMKPVLRFAVRVLMEIFIGET. DNGIDGLKIARE.KIPNLVVLDIGIPKLDGLEVIARLQSLGLP... LRVLVLTGQW=LF C A *:** :* : s: :AA A : : A A*: : : A*: :*: *:*s: AA : : :*:* : A : s*a *: * FixJ KTDYTVHIVDUEEVXSLAf.GFAVKMhI. QSAEAFLAFAPDVR. NGVLVTDLRMPNGVLTDLLRULGDLK NIPS.IV.... ISA E IKPF A*A ::** ** : A :A:::: *: ** * * * : *: A**:A**:** :A: :*::: * :: :*: *** *: * UhpA MITVALIDDHLIVRSGFAQLLGLEPDLQWAEFGSGREALAGLP. GRGVQVCICDISMPDISGLELLSQLPKG. MA...... TIMSVHDSPALVEQALNAGARGFLSKRC * : :*** * * : : ** AA* : : *A* ** *** A* : : * : : * A*A BvgC 672.. RVLVVIDWPNLMLLRQQLDYLGQRVIA..ADSGEAALALIRH.AFDVVITDCNMPGISGYELARRIRAAE&APGYGRTRCILFGFTASAQ MDEAQACRAAGQMCLFKPI : :A:*A :AA: : A* * **A : *:*I * :**:.* *: :A:: : *A :: :* * : * A* SpoOF MMNEKILIVDDQYGIRILLNEVFNKEGYQTF.. QAANGLQALDIVT. KERPDLVLLDMKIPGMDGIEILXRMKVIDENIR. VIIMTAYGELDMIQESKELGALThFAKPF *A:A :: :: :: A:: :A: A: :AAA:A:A::* *:::**: :A : :: **: A** CheY MADKELKFLVVDDFSTRRIVRNLLKIEGFNNV..E.A DGVDAINKLQAGGYGFVISDNMPNMDGTr'rL-LTIRADGAMSA. LPVLMVTAEAKKEDIIAAAQAGASGYVVKPF : : * ****A :* :: * * ** A : :* * : :: * :* *A* : : :A::: : :***A : : * : : A* *A: A* OupR MQENYKNLVVDDIRALLERYLTEQGFQ.VRSVANAEQMDRLL.TRESFH. LMVLDLMLPGEDGLSICRRLRSQSNPMP... IIMVTAXGEEVDRIVGLEIGADDYIPKPF A AAA* :* :: : A A A : :: AA: :* AAA :A AAA : :A:AA AA : :AA:AA *:: :** CheB MSKIRVLSVMSALMRQIMTEIINSHSDMVATAPDPLVARDLIKFN. PDVLTLDVEMPRMDGLLEKLMRLR. PMP...VVtvSSLTGKGSEV.TLRPLELGAIDFVTKPQ A:A A:A A :*::: ::: : A :A AA:: AA :A A: :A: :A A :A: : A AA: :A A :A:AA AA A: :AAA PhoB MARRILVVEDEAPIREVCFVLEQNGFQPVEA.EDYDSAVNQLN.. EPPDLILLDI4LPGGSGIQFIKHLKRE.. SMTRD... IPVVMLTARGEEEDRVRGLETGADDYITKPF : :**:A*** *: : : * :A:: ** : : * A :*:::* *A* A: : * ** :::: **:* :* *:: *** AAAAAAAAAA Dye MQTPHILIVEVrRNTLKSiF EYVM.GAEMHQIL..SEYDINLVIMDINLPGKNGLLLAREL.REQAN. V. MFTGRDKEVDKILGLEIGADDYITKPF A: :: : :A: A A:: : :: A A A*:::: :AA :* :AA*: A AA :: AA: :A ::: :AA :* AAA SpoOA MEXIKVCVADDNRELVSLLSEYIEGQEDMEVIGVAYNGQE LSLF.XEKDPDVLVLDIIMPHLDGLAVLERL.RESDLKKQP....NVIMLTAF GQEDVTIAVDLGASYFILKPF A:: : **: :* : A : A:A A A AAAA: AA AA :**AA:A : :: **:I:*A :: A : A : *A :: AAA NtrC MQRGIAWIVDDDSSIRMV)LERAI.TGAGLSCTTFES.... GNEVLDALT.KTPDVLLSDIRMPGDLALQI KQRHP. MLPVIIMTAHSDLDAAVSAYQQGAFDYLPXPF 103 780 111 109 107 105 110 BvgA NLHEVINAAKAVMAGYTYFPSTTrLSEWRMGDKRKSDSTLISVLSMRMTVLQ. LLA. QGMSIKDIADSMFLSIOVEVSTYI RLLQKL LIDLVELA# :A :A A: :* : :AA :*AA AA ::A A: :A** : :A :*A :: A : A *AA: *s g : FixJ EDTVIIEAIERASEHL...VAAEADVDDRANDIRARLQTLSERERQVLSAWA.. GLPNKSIAYDLDISPRTVEVHRANVMAKMKAKSLPHLVRMALAGGFGPS# :AA: :A ::A: AAAAA :* A:: A AA :A :A*:AA AAAA*:* A: A A A UhpA SPDELIAAVHTVATGG... CYLTPDIAIKLASGRODPLT[REROVAEK. LA. OGMAVKEIAAELGLSPKHVHRANLMEKLGVSNDVELARRMFGN# : A A BvgC GVDALRQRLN... 79( L0 : At : A:1 SpoOF DIDEIRDAVK... il116 CheY OupR TAATLEKLN... : A : : NPRELLARIR... 121 116 209 204 196 CheB LGIREGMLAY... 119 PhoB Dye SPKELVARIK... A:AA A PRELTIRAR.. : :*A : A SpoOA DIIENLVGHIR... A: :: At: : NtrC DIDEAVALVD... 117 115 120 116 FIG. 3. Amino acid sequence comparisons between BvgA, BvgC, and members of bacterial sensory transduction systems that contain receiver domains. Similarities and identities are as described in the legend to Fig. 3. References for members of two-component systems that are not described in the text are as follows: SpoOF (36), SpoOA (37), CheY and CheB (38), and Dye (39). derepressed by modulation signals has recently been identified (43); however, their functions are unknown. Our analysis of the nucleotide sequence has identified three ORFs, designated bvga, bvgb, and bvgc, which reside within the bvg region. In B. pertussis, transposon insertions in bvga or bvgc disrupt bvg function (10), and spontaneous phase variation in the TohamaIII strain results from the insertion (and deletion) of a cytosine residue at position 4129 in bvgc (amino acid 800; ref. 14). In this report we show that insertion of a promotorless CAT gene within bvgc eliminates bvg activity and that nonpolar linker insertion mutations in bvga, bvgb, and bvgc result in a Bvg- phenotype in B. pertussis. The bvgc-cat fusions also confirm that transcription occurs from left to right as shown in Fig. 1. Sequences within the EcoRI-Xho I fragment (Fig. 1) are sufficient for trans activation and modulation of anjhab-iacz transcriptional fusion in E. coli (J.F.M., C.R., and S.F., unpublished data). This suggests that bvg-specific components involved in signal transduction are present within these boundaries. Sequences downstream from bvgc do not show any obvious ORFs, and linker insertions within this region had no effect on bvg activity. Knapp and Mekalanos (43) have recently described the isolation of mutations in the bvg region that constitutively express virulence factors in the presence of modulating conditions. The nature and location of these mutations have not yet been reported. Amino acid sequence similarities suggest that BvgA and BvgC belong to a large family of bacterial regulatory proteins that use conserved transmitter and receiver domains to transduce environmental signals. A growing body of evidence indicates that the mechanism of signal transduction involves autophosphorylation of transmitter proteins, followed by phosphorylation of regulator proteins that contain receiver domains (44-47). In relation to this "two-component motif," the bvg locus is interesting in several respects. Three components, one of which (BvgB) does not contain a transmitter or receiver domain, are needed for regulation. Three linked loci (uhpabc) are also responsible for exogenous induction of sugar-phosphate transport in E. coli (48), and the products of these genes share functional similarities with the proposed Bvg proteins. Another unusual aspect of the B. pertussis system is the presence of a transmitter and a receiver domain in the same polypeptide sequence (see below). A model describing the proposed cellular locations, functions, and interactions of the bvg products is shown in Fig. 4. It is suggested that BvgB and the N-terminal domain of BvgC (residues 1-240) are localized in the periplasm. Residues 60-276 of BvgB share striking similarities with the periplasmic region of BvgC, indicating that these proteins may interact with a common factor, or with each other. According p CM c BvgA (inactive) BvgB I19 BvgA (active) BvgC. < Transmitter module Receiver module FIG. 4. Model for the regulation of virulence factors in B. pertussis. Details are presented in Discussion. P, CM, and C designate periplasm, cytoplasmic membrane, and cytoplasm, respectively. 2.07

Genetics: Arico' et al. to our model, the transmembrane signal in BvgC (residues 240-261) anchors this protein in the cytoplasmic membrane, and the C-terminal transmitter and receiver modules are located in the cytoplasm along with BvgA. Several properties of the bvga sequence suggest that it encodes a transcriptional activator. The presence of a receiver domain and extensive homology with FixJ and UhpA support this contention. We have recently observed that the jhab promoter is activated in E. coli by hyperexpression of BvgA alone (C.R., J.F.M., and S.F., unpublished data), although both BvgB and BvgC are normally required for BvgA activity in both E. coli and B. pertussis. In the absence of modulating signals, we propose that BvgC activates BvgA. It is likely that this activation results from phosphorylation of BvgA by a mechanism involving the transmitter domain of BvgC. BvgB could exert its effect by directly interacting with BvgC, or by inactivating an unidentified inhibitor of BvgC. Although the modulating effect of temperature could act at any level, the inhibitory effects of signals like MgSO4 or nicotinic acid may occur in the periplasm through an interaction with BvgB and/or BvgC. The role ofthe additional receiver module at the C terminus of BvgC is unknown; however, it may be involved in modulating the proposed kinase activity of the transmitter domain. The frameshift mutation described above, which results in a Bvg- phenotype, lies 10 residues downstream from this receiver (14). Deletion of sequences that encode the final 26 amino acids of BvgC also disrupts bvg activity (J.F.M., C.R., and S.F., unpublished data). A role for the C terminus of BvgC in DNA binding can also not be ruled out. We thank D. Relman for advice, critical reading of the manuscript, and transatlantic communications and S. Ricci for oligonucleotide synthesis. This work was supported by Damon Runyon-Walter Winchell Postdoctoral Fellowship DRG-911 (to J.F.M.), by a National Institutes of Health Public Health Service grant and a National Institutes of Health National Research Service Award (to S.S.), and by National Institutes of Health Grant A129345 (to S.F.). B.A., R.G., and R.R. were supported by a grant from ENI (Ente Nazionale Idrocarburi). 1. Miller, J. M., Mekalanos, J. J. & Falkow, S. (1989) Science 243, 916-922. 2. Weiss, A. A. & Hewlett, E. L. (1986) Annu. Rev. Microbiol. 40, 661-686. 3. Urisu, A., Cowell, J. L. & Manclark, C. R. (1986) Infect. Immun. 52, 695-701. 4. Livey, I., Duggleby, C. J. & Robinson, A. (1987) Mol. Microbiol. 1, 203-209. 5. Goldman, W. E., Klapper, D. G. & Baseman, J. B. (1982) Infect. Immun. 36, 782-794. 6. Wardlaw, A. C. & Parton, R. (1983) Pharmacol. Ther. 19, 1-53. 7. Weiss, A. A., Hewlett, E. L., Myers, G. A. & Falkow, S. (1984) J. Infect. Dis. 150, 219-222. 8. Glaser, P., Landant, D., Sezer, O., Pichot, F., Ullmann, A. & Danchin, A. (1988) Mol. Microbiol. 2, 19-30. 9. Nicosia, A. & Rappuoli, R. (1987) J. Bacteriol. 169, 2843-2846. 10. Weiss, A. A., Hewlett, E. K., Myers, G. A. & Falkow, S. (1983) Infect. Immun. 42, 33-41. 11. Weiss, A. A. & Falkow, S. (1984) Infect. Immun. 43, 263-269. 12. Stibitz, S., Weiss, A. A. & Falkow, S. (1988) J. Bacteriol. 170, 2904-2913. 13. Gross, R. & Rappuoli, R. (1988) Proc. Natl. Acad. Sci. USA 85, 3913-3917. Proc. Natl. Acad. Sci. USA 86 (1989) 6675 14. Stibitz, S., Aaronson, W., Monack, D. & Falkow, S. (1989) Nature (London) 338, 266-269. 15. Lacey, B. W. (1960) J. Hyg. 58, 57-93. 16. Idigbe, 0. R., Parton, R. & Wardlaw, A. C. (1981) J. Med. Microbiol. 14, 409-418. 17. Ronson, C. W., Nixon, B. T. & Ausubel, F. M. (1987) Cell 49, 579-581. 18. Simon, R., Priefer, U. & Puhler, A. (1983) Biotechnology 1, 784-791. 19. Close, T. J. & Rodriguez, R. L. (1982) Gene 20, 305-316. 20. Stibitz, S., Black, W. & Falkow, S. (1986) Gene 50, 133-140. 21. Sanger, F., Nicklen, S. & Coulson, A. R. (1977) Proc. Natl. Acad. Sci. USA 74, 5463-5467. 22. Devereux, J., Haeberli, P. & Smithies, 0. (1984) Nucleic Acids Res. 12, 387-395. 23. Relman, D. A., Domenighini, M., Tuomanan, E., Rappuoli, R. & Falkow, S. (1989) Proc. Natl. Acad. Sci. USA 86,2637-2641. 24. Krikos, A., Mutoh, N., Boyd, A. & Simon, M. I. (1983) Cell 33, 615-622. 25. Engelman, D. M., Steitz, T. A. & Goldman, A. (1986) Annu. Rev. Biophys. Chem. 15, 321-353. 26. Leroux, B., Yanofsky, F. M., Winans, C. S., Ward, E. J., Ziegler, F. S. & Nester, E. W. (1987) EMBO J. 6, 849-856. 27. Kuhn, A., Wickner, W. & Kreil, G. (1986) Nature (London) 322, 335-339. 28. Harley, C. B. & Reynolds, R. P. (1987) Nucleic Acids Res. 15, 2343-2361. 29. Brendel, V., Hamm, G. H. & Trifonov, E. N. (1986) J. Biomol. Struct. Dyn. 3, 705-723. 30. Kofoid, E. C. & Parkinson, J. S. (1988) Proc. Natl. Acad. Sci. USA 85, 4981-4985. 31. Mizuno, T., Wurtzel, T. & Inouye, M. (1982) J. Biol. Chem. 257, 13692-13698. 32. David, M., Daveran, M., Batut, J., Dedieu, A., Domergue, O., Ghai, J., Hertig, C., Boistard, P. & Kahn, D. (1988) Cell 54, 671-683. 33. MacFarlane, A. A. & Merrik, M. (1985) Nucleic Acids Res. 13, 7591-7606. 34. Makino, K., Shinagawa, H. H., Amemura, M. & Nakata, A. (1986) J. Mol. Biol. 192, 549-556. 35. Amemura, M., Makino, K., Shinagawa, H. & Nakata, A. (1986) J. Bacteriol. 168, 294-302. 36. Trach, K. A., Chapman, J. W., Piggot, P. J. & Hoch, J. A. (1985) Proc. Natl. Acad. Sci. USA 82, 7260-7264. 37. Ferrari, F. A., Trach, K., LeCoq, D., Spence, J., Ferrari, E. & Hoch, J. A. (1985) Proc. Natl. Acad. Sci. USA 82, 2647-2651. 38. Stock, A., Koshland, D. E. & Stock, J. (1985) Proc. Natl. Acad. Sci. USA 82, 7989-7993. 39. Drury, L. S. & Buxton, R. S. (1985) J. Biol. Chem. 260, 4236-4242. 40. Friedrich, M. J. & Kadner, R. J. (1987) J. Bacteriol. 169, 3556-3563. 41. Lipman. D. J. & Pearson, W. R. (1985) Science 227, 1435-1441. 42. Brennan, R. G. & Matthews, B. W. (1989) J. Biol. Chem. 264, 1903-1906. 43. Knapp, S. & Mekalanos, J. (1988) J. Bacteriol. 170, 5059-5066. 44. Ninfa, A. J., Ninfa, E. G., Lupas, A. N., Stock, A., Magasanik, B. & Stock, J. (1988) Proc. Natl. Acad. Sci. USA 85, 5492-54%. 45. Hess, J. F., Oosawa, K., Kaplan, N. & Simon, M. I. (1988) Cell 53, 79-87. 46. Igo, M. M. & Silhavy, T. J. (1988) J. Bacteriol. 170, 5971-5973. 47. Keener, J. & Kustu, S. (1988) Proc. Natl. Acad. Sci. USA 85, 4976-4980. 48. Weston, L. A. & Kadner, R. J. (1988) J. Bacteriol. 170, 3375-3383.